Real-world Evidence to Estimate Prostate Cancer Costs for First-line Treatment or Active Surveillance

BACKGROUND: Prostate cancer is the most common cancer in men and second leading cause of cancer-related deaths. Changes in screening guidelines, adoption of active surveillance (AS), and implementation of high-cost technologies have changed treatment costs. Traditional cost-effectiveness studies rel...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Eur Urol Open Sci
Egile Nagusiak: Magnani, Christopher J., Bievre, Nicolas, Baker, Laurence C., Brooks, James D., Blayney, Douglas W., Hernandez-Boussard, Tina
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2020
Gaiak:
Prostate Cancer
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7751921/
https://ncbi.nlm.nih.gov/pubmed/33367287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.euros.2020.11.004
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak